
Bioanalysis, Biomarker and Flow Cytometry Assay List
Bioanalysis, Biomarker and Flow Cytometry Assay List. PRA Laboratories—Solutions for Drug Development. Behind every sample waiting to be analyzed,…
Bioanalysis, Biomarker and Flow Cytometry Assay List. PRA Laboratories—Solutions for Drug Development. Behind every sample waiting to be analyzed,…
How can we keep healthcare affordable and accessible to all? How can we use science to benefit humans? Asking Ewoud-Jan van Hoogdalem a question…
We’re committed to meaningfully integrating sustainability considerations into our business practices and culture. The work we do has a global…
Human abuse potential (HAP) studies are conducted to determine the potential abuse of a drug that has rewarding properties. Abuse potential refers to…
Human Abuse Potential (HAP) studies are required for New Drug Approvals of all drugs that have a potential psychoactive effect. The steps of…
Abuse potential refers to the likelihood for a drug to be used in nonmedical situations for its positive psychoactive effects. PRA Health Sciences’…
Extended-release (ER) opioid formulations are often targeted for misuse and abuse because they contain high amounts of opioid. An oral…
Abuse deterrent formulations of opioid medications (ADOs) may help curtail the widespread abuse, misuse, and diversion of these products.With the…
PRA’s state-of-the-art, GLP, compliant Bioanalytical Laboratory in Assen, the Netherlands, offers our clients industry-leading, high quality…